Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada

No abstract available.

Information

Citation

Kuenzig ME, Widdifield J, Bernatsky S, Kaplan GG, Benchimol EI. Lancet Gastroenterol Hepatol. 2022; 7(4):288-9. Epub 2022 Feb 22.

View Source

Contributing ICES Scientists

Research Programs

Chronic Disease & Pharmacotherapy

Associated Sites

ICES Central

Discover More

Journal Article

02/02/2026

Incidence of psychotic disorders by birth cohort: a population-based cohort study in Ontario, Canada

Myran DT, Gibb M, Pugliese M, Fiedorowicz JG, Anderson KK, Ramsay T, Jalal H, Kurdyak P, Solmi M. CMAJ. 2026; 198(4): E118-E127.

Journal Article

30/01/2026

Development and validation of the Predicting Risk of Ischemic Stroke in Malignancy Estimation tool

Lun R, Leentjens J, Cerasuolo JO, Kirkwood D, Kapral MK, Carrier M, Siegal D, Sutradhar R. J Am Heart Assoc. 2026; e045631. Epub 2026 Jan 30.

Journal Article

28/01/2026

Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipients

Acuna SA, Zhao X, Jones-Carr M, Smith G, Naylor K, Hasjim BJ, Chen S, Chan AW, Baxter N, Kim SJ, Bhat M. Int J Cancer. 2026; Jan 28 [Epub ahead of print].

See All